Christos Socrates Mantzoros


Christos Socrates Mantzoros is a Greek-born American internist-endocrinologist, teacher, and researcher. He is a professor of medicine at Harvard Medical School and an adjunct professor at Boston University School of Medicine. In the past, he has also served as a professor at the Harvard T.H. Chan School of Public Health.
He is board certified in internal medicine, and endocrinology & metabolism in Europe and the United States and serves as the chief of endocrinology, diabetes, and metabolism at the VA Boston Healthcare System. He is also the founding director of human nutrition at Beth Israel Deaconess Medical Center, Harvard Medical School, and editor-in-chief of the journal Metabolism: Clinical and Experimental.
Mantzoros has served as a board member on the Hellenic College Holy Cross, as well as the ALBA Graduate Business School of the American College of Greece board of trustees.

Research

Mantzoros researches topics such as human physiology and molecular biology, observational epidemiology studies, and clinical trials treating obesity, diabetes, and other human metabolic diseases. Mantzoros is known for his work on leptin, adiponectin, and the proglucagon family of molecules, as well as the relationship between insulin-like growth factors and cancer. Leptin has been approved by the United States Food and Drug Administration for treating lipodystrophy and severe insulin resistance accompanied by hyperglycemia and hyperlipidemia.
His publications include two books, more than 1,100 scientific papers and also ran over 135 clinical trials.

Other ventures

Mantzoros heads Mantzoros Consulting, LLC. In 2005, he co-founded Intekrin, Inc., which was later acquired by and merged with Coherus, Inc.

Teaching and mentoring

Mantzoros teaches at Harvard Medical School and Boston University School of Medicine.
He is on the ALBA Graduate Business School of the American College of Greece board of trustees.

Awards

Mantzoros has received the following awards:
Other awards include: